Edition:
United Kingdom

ITUS Corp licenses CAR-T technology from Wistar Institute


Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - ITUS Corp :ITUS Corporation licenses CAR-T technology from the Wistar Institute.Itus Corp - ‍executed exclusive worldwide license agreement with Wistar Institute for a Chimeric Antigen Receptor T-Cell (CAR-T) technology.ITUS Corp - has formed a subsidiary, Certainty Therapeutics Inc, to develop and commercialize innovative CAR-T technology​. 

Company Quote

4.22
0.05 +1.20%
21 May 2019